Taking people1. fázis
A first-in-human, dose finding study to evaluate the safety, tolerability and pharmacokinetics of EGL-003 in healthy volunteers followed by adults with autoimmune disease.
Key facts
- Where
- Burgas, Lovech, Pleven, Plovdiv, Sofiya és Stanboliyski, BulgáriaSee the 8 sites
- Phase
- 1. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Bulgária
- Medical Center Medconsult Burgas EOODBurgas, BulgáriaToborzás még nem indult
- University Multiprofile Hospital For Active Treatment Burgas ADBurgas, BulgáriaToborzás még nem indult
- Medical Center Medconsult Pleven OODLovech, BulgáriaToborzás még nem indult
- Medical Center Medconsult Pleven OODPleven, BulgáriaToborzás még nem indult
- Medical Center Etika Ambulatory For Specialized Outpatient Medical Care OODPlovdiv, BulgáriaToborzás még nem indult
- Acibadem City Clinic Tokuda University Hospital EADSofiya, BulgáriaToborzás még nem indult
- Medical Center Excelsior OODSofiya, BulgáriaToborzás még nem indult
- Medical Center I StamboliyskiStanboliyski, BulgáriaToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Egle Therapeutics
- Trial code
- EU 2025-521658-40-00
- Record updated
- 2026. augusztus 28.